David Ellenberger

1.8k total citations
60 papers, 1.1k citations indexed

About

David Ellenberger is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, David Ellenberger has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 13 papers in Oncology and 10 papers in Neurology. Recurrent topics in David Ellenberger's work include Multiple Sclerosis Research Studies (39 papers), Polyomavirus and related diseases (11 papers) and Peripheral Neuropathies and Disorders (9 papers). David Ellenberger is often cited by papers focused on Multiple Sclerosis Research Studies (39 papers), Polyomavirus and related diseases (11 papers) and Peripheral Neuropathies and Disorders (9 papers). David Ellenberger collaborates with scholars based in Germany, Austria and United States. David Ellenberger's co-authors include Tim Friede, Alexander Stahmann, Uwe K. Zettl, Jutta Gärtner, Brenda Huppke, Peter Huppke, Paulus Rommer, Peter Flachenecker, Judith Haas and Wolfgang Brück and has published in prestigious journals such as Circulation, PLoS ONE and Neurology.

In The Last Decade

David Ellenberger

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ellenberger Germany 18 599 300 205 164 143 60 1.1k
Derrick Robertson United States 11 459 0.8× 235 0.8× 65 0.3× 85 0.5× 137 1.0× 46 804
Dalia Rotstein Canada 18 920 1.5× 308 1.0× 151 0.7× 50 0.3× 212 1.5× 61 1.3k
Killian O’Rourke Ireland 17 376 0.6× 156 0.5× 72 0.4× 160 1.0× 138 1.0× 42 1.1k
Lekha Pandit India 20 707 1.2× 625 2.1× 151 0.7× 45 0.3× 76 0.5× 69 1.4k
Francesca Bovis Italy 21 260 0.4× 112 0.4× 202 1.0× 94 0.6× 55 0.4× 116 1.3k
Raed Alroughani Kuwait 24 1.5k 2.5× 483 1.6× 243 1.2× 67 0.4× 335 2.3× 166 2.2k
Jihad Inshasi United Arab Emirates 15 483 0.8× 179 0.6× 69 0.3× 24 0.1× 135 0.9× 68 715
T. Moreau France 10 398 0.7× 132 0.4× 126 0.6× 53 0.3× 130 0.9× 23 884
Christina Caon United States 20 783 1.3× 381 1.3× 122 0.6× 31 0.2× 220 1.5× 36 1.0k
Mark Dolev Israel 18 1.0k 1.7× 441 1.5× 108 0.5× 34 0.2× 141 1.0× 50 1.4k

Countries citing papers authored by David Ellenberger

Since Specialization
Citations

This map shows the geographic impact of David Ellenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ellenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ellenberger more than expected).

Fields of papers citing papers by David Ellenberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ellenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ellenberger. The network helps show where David Ellenberger may publish in the future.

Co-authorship network of co-authors of David Ellenberger

This figure shows the co-authorship network connecting the top 25 collaborators of David Ellenberger. A scholar is included among the top collaborators of David Ellenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ellenberger. David Ellenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellenberger, David, Niklas Frahm, Alexander Stahmann, et al.. (2025). Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosis. Journal of Neurology. 272(9). 609–609.
2.
Frahm, Niklas, David Ellenberger, Alexander Stahmann, et al.. (2024). Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry. Therapeutic Advances in Neurological Disorders. 17. 4233520828–4233520828. 3 indexed citations
3.
Stahmann, Alexander, David Ellenberger, Niklas Frahm, et al.. (2024). Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations. Therapeutic Advances in Neurological Disorders. 17. 4233514132–4233514132. 3 indexed citations
4.
Goereci, Yasemin, David Ellenberger, Paulus Rommer, et al.. (2024). Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry. Journal of Neurology. 271(6). 3409–3416. 7 indexed citations
5.
Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2023). Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study. Journal of Clinical Medicine. 12(11). 3640–3640. 4 indexed citations
6.
7.
Ellenberger, David, et al.. (2023). Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry. Therapeutic Innovation & Regulatory Science. 57(6). 1217–1228. 2 indexed citations
8.
Ellenberger, David, et al.. (2023). Artificial intelligence in automatic passenger counting: cost-efficient validation using the partitioned equivalence test. Transportmetrica A Transport Science. 21(3).
9.
Ellenberger, David, et al.. (2022). Adverse events in MS patients fulfilling or not inclusion criteria of the respective clinical trial – The problem of generalizability. Multiple Sclerosis and Related Disorders. 69. 104422–104422. 3 indexed citations
10.
Ellenberger, David, Tina Parciak, Waldemar Brola, et al.. (2022). Comparison of employment among people with Multiple Sclerosis across Europe. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(2). 3090453853–3090453853. 6 indexed citations
11.
Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2022). SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study. The Lancet Regional Health - Europe. 22. 100502–100502. 17 indexed citations
12.
Frahm, Niklas, David Ellenberger, Peter Flachenecker, et al.. (2022). Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry. Neurology and Therapy. 11(1). 319–336. 3 indexed citations
13.
Frahm, Niklas, Jörg Bätzing, David Ellenberger, et al.. (2021). Prevalence of pediatric multiple sclerosis in Germany: A nationwide population‐based analysis. European Journal of Neurology. 28(9). 3173–3176. 6 indexed citations
14.
Ellenberger, David, Peter Flachenecker, Tim Friede, et al.. (2021). Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry. Scientific Reports. 11(1). 13340–13340. 30 indexed citations
15.
Frahm, Niklas, Jörg Bätzing, David Ellenberger, et al.. (2021). Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis. Therapeutic Advances in Neurological Disorders. 14. 4203329424–4203329424. 7 indexed citations
16.
Ellenberger, David, et al.. (2021). Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care. Multiple Sclerosis Journal. 27(12). 1852–1863. 19 indexed citations
17.
Blaschke, Stefan, David Ellenberger, Peter Flachenecker, et al.. (2021). Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry. Multiple Sclerosis Journal. 28(6). 865–871. 9 indexed citations
18.
Frahm, Niklas, David Ellenberger, Clemens Warnke, et al.. (2021). Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study. Multiple Sclerosis and Related Disorders. 56. 103281–103281. 9 indexed citations
19.
Salter, Amber, Alexander Stahmann, David Ellenberger, et al.. (2020). Data harmonization for collaborative research among MS registries: A case study in employment. Multiple Sclerosis Journal. 27(2). 281–289. 17 indexed citations
20.
Knösel, Michael, et al.. (2015). In-vivo durability of a fluoride-releasing sealant (OpalSeal) for protection against white-spot lesion formation in orthodontic patients. Head & Face Medicine. 11(1). 11–11. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Derrick Robertson Breakdown of academic impact, for papers by Dalia Rotstein Breakdown of academic impact, for papers by Killian O’Rourke Breakdown of academic impact, for papers by Lekha Pandit Breakdown of academic impact, for papers by Francesca Bovis Breakdown of academic impact, for papers by Raed Alroughani Breakdown of academic impact, for papers by Jihad Inshasi Breakdown of academic impact, for papers by T. Moreau Breakdown of academic impact, for papers by Christina Caon Breakdown of academic impact, for papers by Mark Dolev
Rankless by CCL
2026